11/27/2025
A successful human health biotech founder with a $500M exit just made a full pivot to animal health. Why? 👇
Shawn Wilkie and Dr. Ivan Zak sit down with Todd Zion of Akston to discuss his mission to engineer once-every-six-month treatments for pets with chronic diseases like cancer and dermatitis.
🔬 The Innovation: Akston is applying its protein-engineering platform to create cutting-edge biologics that are significantly cheaper and longer-lasting than current options.
🗓️ The Impact: Imagine treatments that reduce dosing to once or twice a year, dramatically reducing cost and compliance stress for pet owners.
💡 The Insight: Todd shares why the regulatory pathway in vet med is a major advantage for de-risking new therapeutics and attracting investment.
Tune in to learn how this human health expertise is about to redefine the standard of care for chronic disease in pets: https://veterinaryinnovationpodcast.com/episodes/once-a-year-dosing-the-future-of-pet-therapeutics/